Clinical trial
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY…
NCT00450437 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00450437 |
|---|---|
| Title | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults |
| Official title | A Phase 3, Multi-center Study to Evaluate Lot to Lot Consistency, Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults and Compare to the Safety and Immune Response to a Licensed Conjugate Meningococcal ACWY Vaccine |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meningococcal Infections, Meningococcal Meningitis |
| Intervention type | Biological |
| Interventions | MenACWY CRM, Meningococcal ACWY Conjugate vaccine |
| Enrollment | 3,539 |
| Start date | Mar 1, 2007 |
| Primary completion | Aug 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Mar 22, 2007 |
| Last update posted | Jan 28, 2015 |
| Countries | United States |
At a glance
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: